Literature DB >> 7812914

Intratumoral DNA heterogeneity of small hepatocellular carcinoma.

S Okada1, H Ishii, H Nose, T Okusaka, A Kyogoku, M Yoshimori, M Sakamoto, S Hirohashi.   

Abstract

BACKGROUND: Intratumoral DNA heterogeneity provides important information regarding biologic and clinical behavior. The purpose of this study was to evaluate the incidence of DNA heterogeneity in small hepatocellular carcinoma (HCC) nodules.
METHODS: The DNA content of 28 surgically resected small HCC nodules (< or = 3.0 cm) was measured using flow cytometry of fresh or frozen samples taken from different parts of each nodule with reference to the macroscopic features.
RESULTS: Of the 28 small HCC nodules, 14 (50.0%) had only DNA diploid stemline characteristics. Five nodules (17.9%) manifested DNA diploid and DNA aneuploidy within the same tumor. Of the remaining nine nodules (32.1%) that showed only DNA aneuploidy, two contained tumor tissues with apparently different DNA content. Thus, DNA heterogeneity was found in 7 (25.0%) of 28 nodules. DNA heterogeneity correlated well with macroscopic histologic features. All four early HCC were composed of only DNA diploid cells, whereas three of six nodule-in-nodule lesions were composed of DNA heterogeneous cells, in which the inner obviously cancerous nodule showed DNA aneuploidy and the outer well differentiated HCC portion demonstrated DNA diploid. Four of 18 overt HCC nodules showed DNA heterogeneity; 2 of these 4 nodules showed both diploid and aneuploid peaks, and the other 2 two showed different aneuploid peaks within the same nodule.
CONCLUSIONS: DNA heterogeneity correlating with macroscopic features is found frequently even in small HCC nodules. Therefore, multiple sampling based on macroscopic features is required for the accurate assessment of DNA ploidy, particularly when the information about DNA ploidy is used as a prognostic indicator.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7812914     DOI: 10.1002/1097-0142(19950115)75:2<444::aid-cncr2820750206>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization.

Authors:  H Tsuda; T Takarabe; N Susumu; J Inazawa; S Okada; S Hirohashi
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  K Ashida; Y Kishimoto; K Nakamoto; K Wada; G Shiota; Y Hirooka; Y Kamisaki; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 3.  Liver transplantation for hepatocellular carcinoma.

Authors:  See Ching Chan
Journal:  Liver Cancer       Date:  2013-08       Impact factor: 11.740

4.  Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  Y Kishimoto; G Shiota; K Wada; M Kitano; K Nakamoto; Y Kamisaki; T Suou; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  [DNA content of the tumor cell. A new prognostic parameter in hepatocellular carcinoma?].

Authors:  T Böttger; J Seifert; M Mörschel; K Lauer; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1996

6.  Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.

Authors:  Shenghua Hao; Ping Fan; Shaofei Chen; Caixue Tu; Chidan Wan
Journal:  J Gastrointest Surg       Date:  2016-11-04       Impact factor: 3.452

7.  Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma: a FISH and FCM analysis of 20 cases.

Authors:  A Kato; K Kubo; F Kurokawa; K Okita; A Oga; T Murakami
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

Review 8.  Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges.

Authors:  Li-Chun Lu; Chih-Hung Hsu; Chiun Hsu; Ann-Lii Cheng
Journal:  Liver Cancer       Date:  2016-03-17       Impact factor: 11.740

Review 9.  Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation.

Authors:  See Ching Chan; Sheung Tat Fan
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

10.  Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion.

Authors:  See Ching Chan; Sheung Tat Fan; Kenneth S H Chok; Tan To Cheung; Albert C Y Chan; James Y Y Fung; Ronnie T P Poon; Chung Mau Lo
Journal:  Hepatol Int       Date:  2011-10-21       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.